Showing results (811-820 of 6,499) with videos related to

Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|June 22, 2017
Critical biological parameters modulate affinity as a determinant of function in T-cell receptor gene-modified T-cellsTimothy T Spear, Yuan Wang, Kendra C Foley, et al.
Cancer Immunology, Immunotherapy : CII|February 24, 2010
MHC-based detection of antigen-specific CD8+ T cell responsesSine Reker Hadrup, Ton N Schumacher
Cancer Immunology, Immunotherapy : CII|January 1, 1988
Studies on cytotoxicity generated in human mixed lymphocyte culture. IV. Interleukin 2 alone or from mixed lymphocyte culture yields natural killer-like cytotoxic cells distinct from allospecific cytotoxic T lymphocytesH Shau, J D Gray, S H Golub
Cancer Immunology, Immunotherapy : CII|August 3, 2018
3-Day monocyte-derived dendritic cells stimulated with a combination of OK432, TLR7/8 ligand, and prostaglandin E2 are a promising alternative for cancer immunotherapyDag Heiro Yi, Nadine Stetter, Kjerstin Jakobsen, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1986
Distribution of intrapleural and intravenous Corynebacterium parvum in humans; 99mTc-, and 131I-labeled bacteriaM Kaufmann, J Marqverson, K E Stanley, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1986
Immunomodulating activity in supernatants from EBV immortalized lymphocytesB A Blazar, L M Sutton, M Strome
Cancer Immunology, Immunotherapy : CII|May 29, 2017
Macrophage-derived interleukin-1beta promotes human breast cancer cell migration and lymphatic adhesion in vitroSarah J Storr, Sabreena Safuan, Narmeen Ahmad, et al.
Cancer Immunology, Immunotherapy : CII|May 31, 2017
Peripheral blood T cell alterations in newly diagnosed diffuse large B cell lymphoma patients and their long-term dynamics upon rituximab-based chemoimmunotherapySimone Battella, M Christina Cox, Raffaella La Scaleia, et al.
Cancer Immunology, Immunotherapy : CII|October 14, 2009
FTY720 and SEW2871 reverse the inhibitory effect of S1P on natural killer cell mediated lysis of K562 tumor cells and dendritic cells but not on cytokine releaseJohannes Rolin, Kristin L Sand, Eirunn Knudsen, et al.
Cancer Immunology, Immunotherapy : CII|September 8, 2016
Mass spectrometric analysis of the HLA class I peptidome of melanoma cell lines as a promising tool for the identification of putative tumor-associated HLA epitopesAndreas Gloger, Danilo Ritz, Tim Fugmann, et al.
Pageof 650